Protocol for a randomized controlled trial investigating the effects of sleep extension on body weight and learning in children (More2Sleep) - Takeaways - MDSpire

Protocol for a randomized controlled trial investigating the effects of sleep extension on body weight and learning in children (More2Sleep)

  • By

  • Cecilie H. Rasmussen

  • Nadia D. Neesgaard

  • Malene Skriver-Bayer

  • Caroline S. Muushardt

  • Eva Leedo-Townend

  • Jonas R. Bjørndal

  • Maria I. Rosenkrans

  • Andreas Wulff-Abramsson

  • Louise Mejer

  • Kathrine Skak Madsen

  • Line K. Johnsen

  • Hartwig R. Siebner

  • Nanette M. Debes

  • Chantelle N. Hart

  • Guy Plasqui

  • Anders Grøntved

  • Glen Nielsen

  • Poul J. Jennum

  • Jesper Lundbye-Jensen

  • Faidon Magkos

  • May 11, 2026

  • 0 min

Share

  • 1

    The More2Sleep trial investigates the effects of increased sleep duration on weight management and cognitive skills in children aged 6-12 years.

  • 2

    The study involves 142 short-sleeping children, randomly assigned to either a sleep extension group or a control group for 12 weeks.

  • 3

    Co-primary outcomes include changes in BMI z-score and learning ability, with secondary outcomes assessing various health and cognitive metrics.

  • 4

    Substudies will explore metabolic and cognitive mechanisms affected by sleep duration, including MRI assessments.

  • 5

    The findings aim to inform future sleep recommendations and strategies to combat obesity and enhance cognitive development in children.

Original Source(s)

Protocol for a randomized controlled trial investigating the effects of sleep extension on body weight and learning in children (More2Sleep)

  • by Cecilie H. Rasmussen, Nadia D. Neesgaard, Malene Skriver-Bayer, Caroline S. Muushardt, Eva Leedo-Townend, Jonas R. Bjørndal, Maria I. Rosenkrans, Andreas Wulff-Abramsson, Louise Mejer, Kathrine Skak Madsen, Line K. Johnsen, Hartwig R. Siebner, Nanette M. Debes, Chantelle N. Hart, Guy Plasqui, Anders Grøntved, Glen Nielsen, Poul J. Jennum, Jesper Lundbye-Jensen, Faidon Magkos

  • May 11, 2026

Related Content

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children

Comparative evaluation of SBS and RASS for sedation assessment in mechanically ventilated children